XML 73 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2017
Amounts Charged to Income for Employees Incentive Compensation Plans
The amounts charged to income for Progressive and ARX incentive compensation plans for the years ended December 31, were:
 
2017
 
2016
 
2015
(millions)
Pretax

After Tax

 
Pretax

After Tax

 
Pretax

After Tax

Non-equity incentive plans  cash
$
461.3

$
299.8

 
$
386.8

$
251.4

 
$
337.7

$
219.5

Equity incentive plans:
 
 
 
 
 
 
 
 
     Equity awards
92.9

60.4

 
80.9

52.6

 
64.5

41.9

     Liability awards
2.5

1.6

 
4.3

2.8

 
1.7

1.1

Assets Held in Deferral Plan Irrevocable Grantor Trust Account
The Deferral Plan Irrevocable Grantor Trust account held the following assets at December 31:
 
(millions)
2017

2016

Progressive common shares
$
128.2

$
122.2

Other investment funds2
167.0

136.9

Total
$
295.2

$
259.1

1 Included 4.4 million and 4.7 million common shares as of December 31, 2017 and 2016, respectively, to be distributed in common shares.
2 Amount is included in other assets on the balance sheet.
Employee  
Summary of Restricted Stock Activity
A summary of all employee restricted equity award activity during the years ended December 31, follows:
 
2017
 
2016
 
2015
Restricted Equity Awards
Number of Shares1

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares1 

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares1 

Weighted
Average
Grant
Date Fair
Value

Beginning of year
6,951,373

$
26.18

 
7,725,227

$
23.37

 
9,051,564

$
21.27

Add (deduct):
 
 
 
 
 
 
 
 
Granted
2,383,475

32.01

 
1,870,660

31.54

 
2,489,976

25.20

Vested
(3,220,671
)
22.53

 
(2,422,700
)
21.50

 
(3,682,644
)
19.53

Forfeited
(255,329
)
28.03

 
(221,814
)
24.64

 
(133,669
)
21.63

End of year3,4
5,858,848

$
30.47

 
6,951,373

$
26.18

 
7,725,227

$
23.37

1 Includes restricted stock units; 2015 also includes restricted stock. Upon vesting, all units will be converted on a one-for-one basis into Progressive common shares funded from existing treasury shares. All performance-based awards are included at their target amounts.
2 We reinvest dividend equivalents on restricted stock units. For 2017, 2016, and 2015, the number of units “granted” shown in the table above includes 157,396, 165,045, and 196,947 of dividend equivalent units, respectively, at a weighted average grant date fair value of $0, since the dividends were factored into the grant date fair value of the original grant.
3 At December 31, 2017, the number of shares included 1,513,779 performance-based units at their target amounts. We expect 3,244,111 units to vest based upon our current estimates of the likelihood of achieving the pre-determined performance goals applicable to each award.
4 At December 31, 2017, the total unrecognized compensation cost related to unvested equity awards was $87.1 million, which includes performance-based awards at their currently estimated vesting value. This compensation expense will be recognized into the income statement over the weighted average vesting period of 2.2 years.
Director  
Summary of Restricted Stock Activity
A summary of all directors’ restricted stock activity during the years ended December 31, follows:
 
2017
 
2016
 
2015
Restricted Stock
Number of
Shares

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares

Weighted
Average
Grant
Date Fair
Value

Beginning of year
55,839

$
33.24

 
89,427

$
27.23

 
81,579

$
25.45

Add (deduct):
 
 
 
 
 
 
 
 
Granted
53,284

40.54

 
55,839

33.24

 
89,427

27.23

Vested
(55,839
)
33.24

 
(89,427
)
27.23

 
(81,579
)
25.45

End of year
53,284

$
40.54

 
55,839

$
33.24

 
89,427

$
27.23


Employee Stock Option  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
A summary of all ARX employee stock option activity since acquisition, follows:
 
2017
 
2016
 
2015
Options Outstanding
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

Beginning of year
24,995

$
526.46

 
24,995

$
526.46

 
NA

NA

At acquisition date 4/1/2015
NA

NA

 
NA

NA

 
26,000

$
513.72

Add (deduct):
 
 
 
 
 
 
 
 
Exercised1
(2,445
)
174.65

 
0

0

 
(1,005
)
197.01

End of year
22,550

$
564.60

 
24,995

$
526.46

 
24,995

$
526.46

Exercisable, end of year
17,950

$
517.75

 
16,995

$
438.77

 
12,995

$
386.69

NA = Not Applicable
1 At the time of exercise in 2017 and 2015, the value earned by the option holders was $2.9 million and $1.1 million, respectively.
 
2017
 
2016
 
2015
Non-Vested Options Outstanding
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

Beginning of year
8,000

$
712.74

 
12,000

$
677.81

 
NA

NA

At acquisition date 4/1/2015
NA

NA

 
NA

NA

 
14,800

$
675.55

Add (deduct):
 
 
 
 
 
 
 
 
Vested
(3,400
)
665.79

 
(4,000
)
607.95

 
(2,800
)
665.85

End of year1
4,600

$
747.45

 
8,000

$
712.74

 
12,000

$
677.81

NA = Not Applicable
1 At December 31, 2017, 2016, and 2015, the remaining unrecognized compensation cost related to unvested options was $0.7 million, $1.6 million, and $2.9 million, respectively, and the remaining weighted average vesting period on the unvested awards was 1.01 years, 1.36 years, and 1.72 years, respectively.